发明公开
EP1012238A1 PEPTIDES AND PEPTIDE-LOADED ANTIGEN PRESENTING CELLS FOR THE ACTIVATION OF CTL
失效
肽和用肽LOADED,抗原呈递细胞毒性T细胞的活化
- 专利标题: PEPTIDES AND PEPTIDE-LOADED ANTIGEN PRESENTING CELLS FOR THE ACTIVATION OF CTL
- 专利标题(中): 肽和用肽LOADED,抗原呈递细胞毒性T细胞的活化
-
申请号: EP98906086.8申请日: 1998-01-30
-
公开(公告)号: EP1012238A1公开(公告)日: 2000-06-28
- 发明人: TSAI, Van , SOUTHWOOD, Scott , SIDNEY, John , SETTE, Alessandro , CELIS, Esteban
- 申请人: Epimmune, Inc.
- 申请人地址: 6555 Nancy Ridge Drive,Suite 200 San Diego,California 92121 US
- 专利权人: Epimmune, Inc.
- 当前专利权人: Epimmune, Inc.
- 当前专利权人地址: 6555 Nancy Ridge Drive,Suite 200 San Diego,California 92121 US
- 代理机构: Cripps, Joanna Elizabeth
- 优先权: US36696P 19970131
- 国际公布: WO9833888 19980806
- 主分类号: C12N5/06
- IPC分类号: C12N5/06 ; C12N5/08
摘要:
Methods for generating antigen-specific cytotoxic T lymphocytes (CTLs) in vitro are presented in conjuntion with methods for using these CTLs for therapy in vivo. The antigen presenting cells (APCs) used herein notably include dentritic cells pretreated with GM-CSF and IL-4. Antigen-specific CTLs were obtained by incubating CD8 preparations in the presence of APCs that bound desired peptides. IL-7 was generally added at day 1 of the incubation; IL-10 was generally added one day later and during restimulation. The invention also comprises methods for using peptide pulsed dentritic cells to identify novel MHC Class I-restricted tumor antigens and subdominant epitopes.
信息查询